Decrease in proliferation after ENU-exposure as decrease in BrdU immunostaining. by Vivian Capilla-Gonzalez (336046)

“…Scale bar: A 50 µm, C 100 µm.</p>…”

Decreased numbers of motor neurons in Tc1 and Dp(16)1Yey mice. by Sheona Watson-Scales (586942)

Resveratrol decreases cell proliferation in a time and dose dependent manner. by Mehtap Kilic Eren (591048)

Stx16-depleted MDCK monolayer show decreased transepithelial resistance (TER). by Jae-Joon Jung (139625)

Nanoparticle formulation decreases curcumin cytotoxicity. by Upendhar Gandapu (208623)

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…<p>(A) COA3 and (B) COA6 PDX cells were plated as single cell suspension in serum-free, conditioned media onto 96-well low attachment plates using serial dilutions with 5000, 1000, 100, 50, 20, 10, and 1 cell per well. Cells were treated with GSK343 (0, 5 μM). …”

Resveratrol treatment decreases SIRT1 and SIRT2 levels. by Mehtap Kilic Eren (591048)

Germ cell size decreases before corpse formation. by Tea Kohlbrenner (19476160)

Stat1 activation is strongly decreased by MNV-S99 infection. by Sandra Niendorf (2832785)

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

Sporulation is decreased in a Δ<i>mas</i> mutant. by Sarah Fremgen (102742)

miR-100 decreases tumor size. by Bahauddeen M. Alrfaei (484859)

Expression of 5-hmC was decreased in ESCC tissues. by Xuejiao Shi (1684186)

miR-24 levels decrease with replicative senescence. by Ashish Lal (43926)

VGB decreased activation of the mTOR pathway in vivo. by Bo Zhang (6559)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Decreased glucose availability increased sensitivity of neurons to glutamate excitation. by Ujval Anilkumar (4598182)

Viability of microencapsulated FP ICCs decreased with time post-transplantation. by Vijayaganapathy Vaithilingam (390354)

“…<p>A) Fluorescent images of encapsulated FP ICCs stained with 6-CFDA for viable cells (green) and PI for non-viable cells (red) to assess viability at (A) pre-transplantation, (B) day 1, (C) day 3, (D) day 7, (E) day 14 and (F) day 21 post-transplantation. B) Viability decreased with time post-transplantation. Values are mean ± SEM (n = 100 microcapsules/mice for each time point); *p&lt;0.05 viability for days 7 to 21 when compared to pre-transplantation control and days 1 and 3 post-transplantation; #p&lt;0.05 viability for days 14 and 21 when compared to day 7 post-transplantation (one-way ANOVA with post-hoc Tukey-Kramer Multiple-Comparison test).…”

BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion by Saeed Katiraei (3956147)

“…Male C57BL/6 mice underwent syngeneic BMT using lethal irradiation. After a recovery period of 8 weeks they were fed a low-fat diet (LFD) or HFD for 16 weeks. …”

The LCS stream is absent in E16.5 <i>Emx1</i>-cKO mice. by Sathish Venkataramanappa (10331993)